amikacin has been researched along with Cancer of Colon in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bayle, C; Bourhis, JH; Cartron, J; Gautier, E; Pico, JL; Tchernia, G | 1 |
| Fujimoto, M; Sakai, K; Ueda, T | 1 |
1 trial(s) available for amikacin and Cancer of Colon
| Article | Year |
|---|---|
[Significance of amikacin administered orally prior to operation for prevention of postoperative infections in colonic cancer surgery].
Topics: Administration, Oral; Aged; Aged, 80 and over; Amikacin; Clinical Trials as Topic; Colonic Neoplasms; Feces; Female; Humans; Metronidazole; Premedication; Preoperative Care; Surgical Wound Infection | 1986 |
1 other study(ies) available for amikacin and Cancer of Colon
| Article | Year |
|---|---|
Parvovirus B19 associated neutropenia. Treatment with Rh G-CSF.
Topics: Adenocarcinoma; Adult; Amikacin; Colonic Neoplasms; DNA, Viral; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Injections, Intravenous; Liver Neoplasms; Neutropenia; Parvoviridae Infections; Parvovirus B19, Human; Pefloxacin; Penicillanic Acid; Piperacillin; Recombinant Proteins; Tazobactam | 1997 |